Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Prime Medicine, Inc. - Common Stock (NQ:PRME)

1.270 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,863,569
Open 1.220
Bid (Size) 1.250 (10)
Ask (Size) 1.300 (42)
Prev. Close 1.270
Today's Range 1.210 - 1.350
52wk Range 1.110 - 8.144
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Citi Downgrade Sparks Retail Chatter On Prime Medicine Amid Cash Runway Uncertainty
The biotech firm announced a restructuring to focus on its liver disease programs while cutting costs and workforce amid ongoing development challenges. 
Via Stocktwits
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga

Performance

YTD
-57.5%
-57.5%
1 Month
-23.5%
-23.5%
3 Month
-56.2%
-56.2%
6 Month
-61.9%
-61.9%
1 Year
-80.5%
-80.5%

More News

Read More
This MongoDB Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
6 Analysts Assess Prime Medicine: What You Need To Know
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Prime Medicine Announces Layoffs, CEO Transition: Retail Gets More Bullish
Via Stocktwits
Topics Workforce
Exposures Layoff
Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine Reports First Quarter 2025 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
Cathie Wood's Ark Invest Offloads Uipath, Prime Medicine, And Repare Therapeutics
Via Benzinga
Why Prime Medicine Stock Was Climbing Higher This Week
Via The Motley Fool
Why Prime Medicine Stock Is Soaring Today
Via The Motley Fool
Prime Medicine Unveils Program for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
From Prime Medicine, Inc.
Via GlobeNewswire
Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta
Via Benzinga
Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine to Present at 43rd Annual J.P. Morgan Healthcare Conference
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine to Participate in Upcoming Investor Conferences
From Prime Medicine, Inc.
Via GlobeNewswire
12 High-Growth Stocks That Could Deliver Parabolic Returns
Via The Motley Fool
Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress
From Prime Medicine, Inc.
Via GlobeNewswire
Why I Keep Buying These 14 Incredible Growth Stocks
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson’s Disease, at Upcoming Scientific Meetings
From Prime Medicine, Inc.
Via GlobeNewswire
Why Prime Medicine Stock Soared Nearly 12% Higher on Monday
Via The Motley Fool
Dow Dips 300 Points; Emcore Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities

Frequently Asked Questions

Is Prime Medicine, Inc. - Common Stock publicly traded?
Yes, Prime Medicine, Inc. - Common Stock is publicly traded.
What exchange does Prime Medicine, Inc. - Common Stock trade on?
Prime Medicine, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Prime Medicine, Inc. - Common Stock?
The ticker symbol for Prime Medicine, Inc. - Common Stock is PRME on the Nasdaq Stock Market
What is the current price of Prime Medicine, Inc. - Common Stock?
The current price of Prime Medicine, Inc. - Common Stock is 1.270
When was Prime Medicine, Inc. - Common Stock last traded?
The last trade of Prime Medicine, Inc. - Common Stock was at 05/28/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.